spot_img
29 C
Philippines
Thursday, April 25, 2024

Top pharma reaffirms dedication to ongoing advancements in medicine

- Advertisement -
- Advertisement -

Unilab Inc. has made a firm commitment to the relentless development of groundbreaking medicines. This dedication holds even greater significance now, as the world navigates through the ongoing pandemic and faces the challenges posed by abnormal weather patterns.

According to Dr. Jonas Policarpio, Unilab Consumer Health Group Medical Director, recent data from the Department of Health reveals a concerning trend. Over the past two weeks, the country has been witnessing approximately 1,000 new COVID cases each day, with Metro Manila experiencing a positivity rate of 25 percent.

In light of these circumstances, Dr. Policarpio emphasizes the importance of adopting a proactive approach and remaining vigilant about our health and safety, as well as that of our loved ones. The increasing number of COVID cases and the unpredictable weather necessitate an advanced mindset and constant preparedness.

Unilab’s Solmux Advance Suspension is a cough medicine that has been scientifically proven to be more effective in treating cough with phlegm

“With more people getting sick due to COVID and sudden changes in the weather, we need to have an advanced mindset and be on guard always when it comes to our health and safety and those of our loved ones,” Policarpio stressed.

In response to the current situation, Unilab has recently introduced Solmux Advance Suspension, a cough medicine that has been scientifically proven to be more effective in treating cough with phlegm. This enhanced formulation contains double the amount of Zinc, providing a more potent solution for individuals experiencing this type of cough.

- Advertisement -

“Our studies showed that the combination of Carbocisteine and Zinc is very effective in treating cough with phlegm, which prompted us to offer to the public Solmux Advance, the first cough medicine in the country and probably the whole world to be fortified with Zinc,” Leevan Fong, Brand Manager of the Solmux line, shared. 

Based on an observational study which was done by an independent investigator, the combination of 500 mg Carbocisteine and 5 mg Zinc present in Solmux Advance Capsule has been proven to have reduced the symptoms of cough in 3 days and resolution in just 5.52 days.

Carbocisteine causes phlegm to be less thick and sticky and thus easier to cough up and expel, while Zinc has been found to play an important role in highly proliferating cells of the human body, like the immune system.

The new variant, Solmux Advance Suspension, contains 27.44 mg of Zinc Sulfate Monohydrate for every 60-ml bottle. This means that every 10-ml dose of Solmux Advance Suspension has a potent combination of about 500 mg of Carbocisteine and 10 mg of Zinc.

“We have been receiving positive reviews of the product from our customers and trade partners. We are elated that the public quickly embraced Solmux Advance Suspension. The soothing menthol effect made them instantly feel relief after taking the suspension,” Fong concluded.

- Advertisement -

LATEST NEWS

Popular Articles